Medicare Advantage

Elevance’s $342 million payment to CMS amid a looming Medicare Advantage sanctions threat signals continued federal scrutiny of MA plan conduct, risk adjustment, and compliance under the Trump administration—an immediate concern for payers and provider groups tied to MA value-based contracts. For health systems and ACO-aligned providers, the development raises near-term risk around plan behavior, revenue predictability, and delegated-risk arrangements as CMS enforcement pressure intersects with ongoing MA margin and utilization-management tensions. Source: Becker’s Hospital Review newsletter.